Conestoga Capital Advisors’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $247K | Sell |
2,090
-627
| -23% | -$72.4K | 0.01% | 101 |
|
|
2026
Q1 | $325K | Sell |
2,717
-990
| -27% | -$130K | 0.01% | 99 |
|
|
2025
Q4 | $505K | Sell |
3,707
-1,142
| -24% | -$164K | 0.01% | 99 |
|
|
2025
Q3 | $715K | Buy |
4,849
+20
| +0.4% | +$2.77K | 0.01% | 97 |
|
|
2025
Q2 | $625K | Buy |
4,829
+50
| +1% | +$6.05K | 0.01% | 100 |
|
|
2025
Q1 | $571K | Hold |
4,779
| – | – | 0.01% | 106 |
|
|
2024
Q4 | $554K | Hold |
4,779
| – | – | 0.01% | 105 |
|
|
2024
Q3 | $645K | Sell |
4,779
-115
| -2% | -$15.4K | 0.01% | 101 |
|
|
2024
Q2 | $664K | Buy |
4,894
+680
| +16% | +$92.5K | 0.01% | 104 |
|
|
2024
Q1 | $545K | Sell |
4,214
-315
| -7% | -$38.1K | 0.01% | 109 |
|
|
2023
Q4 | $518K | Sell |
4,529
-150
| -3% | -$15K | 0.01% | 110 |
|
|
2023
Q3 | $426K | Buy |
4,679
+397
| +9% | +$40.9K | 0.01% | 111 |
|
|
2023
Q2 | $482K | Sell |
4,282
-448
| -9% | -$47.4K | 0.01% | 105 |
|
|
2023
Q1 | $495K | Sell |
4,730
-140
| -3% | -$14.6K | 0.01% | 109 |
|
|
2022
Q4 | $538K | Sell |
4,870
-385
| -7% | -$40.4K | 0.01% | 108 |
|
|
2022
Q3 | $459K | Sell |
5,255
-50
| -0.9% | -$4.54K | 0.01% | 112 |
|
|
2022
Q2 | $415K | Buy |
5,305
+15
| +0.3% | +$1.24K | 0.01% | 120 |
|
|
2022
Q1 | $451K | Buy |
5,290
+180
| +4% | +$17.2K | 0.01% | 122 |
|
|
2021
Q4 | $613K | Sell |
5,110
-5
| -0.1% | -$621 | 0.01% | 115 |
|
|
2021
Q3 | $633K | Buy |
5,115
+50
| +1% | +$6.43K | 0.01% | 116 |
|
|
2021
Q2 | $608K | Buy |
5,065
+425
| +9% | +$48.5K | 0.01% | 114 |
|
|
2021
Q1 | $488K | Sell |
4,640
-20
| -0.4% | -$2.03K | 0.01% | 114 |
|
|
2020
Q4 | $474K | Sell |
4,660
-320
| -6% | -$30.1K | 0.01% | 122 |
|
|
2020
Q3 | $419K | Sell |
4,980
-900
| -15% | -$70.1K | 0.01% | 124 |
|
|
2020
Q2 | $382K | Buy |
5,880
+240
| +4% | +$15.8K | 0.01% | 127 |
|
|
2020
Q1 | $367K | Sell |
5,640
-375
| -6% | -$29.6K | 0.01% | 116 |
|
|
2019
Q4 | $474K | Buy |
6,015
+895
| +17% | +$69.7K | 0.01% | 117 |
|
|
2019
Q3 | $408K | Sell |
5,120
-240
| -4% | -$18.9K | 0.01% | 102 |
|
|
2019
Q2 | $448K | Buy |
5,360
+200
| +4% | +$15.9K | 0.01% | 102 |
|
|
2019
Q1 | $408K | Buy |
5,160
+350
| +7% | +$25.5K | 0.01% | 105 |
|
|
2018
Q4 | $321K | Buy |
+4,810
| New | +$333K | 0.01% | 107 |
|
Other funds holding XYL
Conestoga Capital Advisors's XYL Position: Q2 2026 in Review
Conestoga Capital Advisors reduced its Xylem (XYL) stake by 23% in Q2 2026, selling an estimated $72.4K and leaving 2,090 shares worth $247K. The position accounts for 0.01% of the portfolio, ranked #101.
Conestoga Capital Advisors first reported a position in XYL in Q4 2018 and has held it in 31 quarters since. The position peaked at $715K in Q3 2025. 1,092 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Conestoga Capital Advisors held 2,090 shares of Xylem worth $247K as of Q2 2026.
- Conestoga Capital Advisors sold 627 Xylem shares in Q2 2026, an estimated $72.4K.
- Xylem made up 0.01% of Conestoga Capital Advisors's portfolio in Q2 2026, its #101 holding.
- Conestoga Capital Advisors first reported a position in Xylem in Q4 2018 and has held it in 31 quarters since.
- Conestoga Capital Advisors's Xylem position peaked at $715K in Q3 2025.
- 1,092 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Conestoga Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.